Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 cDNA cloning and properties of glycogen synthase kinase-3.

× No keyword cloud information.

31 in total

1. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility.

Authors: Gerardo Morfini; Györgyi Szebenyi; Ravindhra Elluru; Nancy Ratner; Scott T Brady
Journal: EMBO J Date: 2002-02-01 Impact factor: 11.598

2. First computational chemistry multi-target model for anti-Alzheimer, anti-parasitic, anti-fungi, and anti-bacterial activity of GSK-3 inhibitors in vitro, in vivo, and in different cellular lines.

Authors: Isela García; Yagamare Fall; Generosa Gómez; Humberto González-Díaz
Journal: Mol Divers Date: 2010-10-08 Impact factor: 2.943

3. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.

Authors: Roman Kulikov; Karen A Boehme; Christine Blattner
Journal: Mol Cell Biol Date: 2005-08 Impact factor: 4.272

Review 4. Cardiac myosin-binding protein C: hypertrophic cardiomyopathy mutations and structure-function relationships.

Authors: Vasco Sequeira; E Rosalie Witjas-Paalberends; Diederik W D Kuster; Jolanda van der Velden
Journal: Pflugers Arch Date: 2013-11-17 Impact factor: 3.657

5. Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia.

Authors: Florence F Wagner; Lina Benajiba; Arthur J Campbell; Michel Weïwer; Joshua R Sacher; Jennifer P Gale; Linda Ross; Alexandre Puissant; Gabriela Alexe; Amy Conway; Morgan Back; Yana Pikman; Ilene Galinsky; Daniel J DeAngelo; Richard M Stone; Taner Kaya; Xi Shi; Matthew B Robers; Thomas Machleidt; Jennifer Wilkinson; Olivier Hermine; Andrew Kung; Adam J Stein; Damodharan Lakshminarasimhan; Michael T Hemann; Edward Scolnick; Yan-Ling Zhang; Jen Q Pan; Kimberly Stegmaier; Edward B Holson
Journal: Sci Transl Med Date: 2018-03-07 Impact factor: 17.956

10. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.

Authors: M-L Selenica; H S Jensen; A K Larsen; M L Pedersen; L Helboe; M Leist; J Lotharius
Journal: Br J Pharmacol Date: 2007-10-01 Impact factor: 8.739

cDNA cloning and properties of glycogen synthase kinase-3.

1. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility.

2. First computational chemistry multi-target model for anti-Alzheimer, anti-parasitic, anti-fungi, and anti-bacterial activity of GSK-3 inhibitors in vitro, in vivo, and in different cellular lines.

3. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.

Review 4. Cardiac myosin-binding protein C: hypertrophic cardiomyopathy mutations and structure-function relationships.

5. Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia.

Review 6. GSK3 takes centre stage more than 20 years after its discovery.

Review 7. Neuroprotective strategies for HIV-1 associated dementia.

8. Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer.

Review 9. Tau-based treatment strategies in neurodegenerative diseases.

10. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.